JN

John Niemi

Executive Chairman and Founder

Armas Pharmaceuticals

Armas Pharmaceuticals Pipeline

DrugIndicationPhase
Lidocaine Jelly 2%Local AnesthesiaANDA Approved
Portfolio from Steriscience PartnershipVariousANDA Development/Filing